[Lys(Ac)18]-Histone H3 (1-21)-GGK(Biotin)-NH2 - 1 mg
- Cat.Number : AS-64638-1
- Manufacturer Ref. :
-
Availability :
In stock
This peptide is Histone H3 amino acid residues 1-21. It is acetylated at lysine 18 with a C-terminal GG linker followed by a biotinylated lysine. The acetylation of histone H3 at lysine 18 is used to predict prostrate cancer recurrence and clinical outcome of patients with both lung and kidney cancer. Provided at >95% peptide purity, this peptide was dissolved in distilled water at 1 mg/ml and re-lyophilized to powder form.
Specifications
| Chemistry | |
| Sequence one letter code |
|
|---|---|
| Sequence three letter code |
|
| Molecular Mass/ Weight |
|
| Modification | |
| Conjugation type |
|
| Modification Name | |
| Conjugation |
|
| Quantity & Purity | |
| Purity |
|
| Storage & stability | |
| Form |
|
| Storage Conditions |
|
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage |
|
| Source | |
| Source / Species |
|
You may also be interested in the following product(s)
Citations
Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.
PNAS . 2014 Mar 10 ; 111(12) E1072 | DOI : 10.1073/pnas.1319122111
- C. Das
References
Global Levels of Histone Modifications Predict Prognosis in Different Cancers
Am J Pathol . 2009 May 01 ; 174(5) 1619 | DOI : https://doi.org/10.2353/ajpath.2009.080874
- DB. Seligson